![](https://acist.com/wp-content/uploads/2021/02/ACIST_Lockup_NavvusII_WhiteCropped-1024x194.png)
Rapid Exchange FFR MicroCatheter
![](https://acist.com/wp-content/uploads/2021/02/ACIST_Lockup_NavvusII_WhiteCropped-1024x194.png)
Rapid Exchange FFR MicroCatheter
Product Benefits
![](https://acist.com/wp-content/uploads/2021/02/Enhanced.jpg)
Enhanced Performance
Featuring improved flexibility1, reduced lesion entry profile2 and streamlined contouring to allow navigation of complex diseases.
![](https://acist.com/wp-content/uploads/2021/02/maximize-control.jpg)
Maximized Control
Enables the physician to use 0.014” guidewire of choice and maintain wire position throughout the procedure including pullback and post-PCI assessments.
![](https://acist.com/wp-content/uploads/2021/02/002.jpg)
Consistent & Accurate
Fiber-optic sensor technology may be less susceptible to drift when compared to traditional pressure wires.3
STREAMLINED CROSSING PROFILE for Improved Crossability
![](https://acist.com/wp-content/uploads/2021/02/cross-p-left.png)
13%2
Reduced Lesion Entry Profile
![](https://acist.com/wp-content/uploads/2021/02/cross-p-right-300x58-1.png)
28%1
Improved Flexibility
![](https://acist.com/wp-content/uploads/2021/11/Navvus-II-I-1024x357.jpg)
*Based on user feedback.
Reference
1. TR-07888: Compared with Navvus® II FFR MicroCatheter in benchtop testing. Data on file at ACIST. May not be indicative of clinical performance.
2. TR-08707: Compared with Navvus® II FFR MicroCatheter in benchtop testing. Data on file at ACIST. May not be indicative of clinical performance.
3. William F. Fearon , Jeffrey W. Chambers, Arnold H. Seto, Ian J. Sarembock, Ganesh Raveendran, Charlotte Sakarovitch, Lingyao Yang, Manisha
Desai, Allen Jeremias, and Matthew J. Price and for the ACIST-FFR Study Investigators. Originally published15 Dec 2017https://doi.org/10.1161/
CIRCINTERVENTIONS.117.005905Circulation: Cardiovascular Interventions. 2017;10:e005905